119 related articles for article (PubMed ID: 33410342)
21. KLF4 is a FOXO target gene that suppresses B cell proliferation.
Yusuf I; Kharas MG; Chen J; Peralta RQ; Maruniak A; Sareen P; Yang VW; Kaestner KH; Fruman DA
Int Immunol; 2008 May; 20(5):671-81. PubMed ID: 18375530
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes.
Li W; Jiang Z; Li T; Wei X; Zheng Y; Wu D; Yang L; Chen S; Xu B; Zhong M; Jiang J; Hu Y; Su H; Zhang M; Huang X; Geng S; Weng J; Du X; Liu P; Li Y; Liu H; Yao Y; Li P
Mol Cancer; 2015 Feb; 14():26. PubMed ID: 25644173
[TBL] [Abstract][Full Text] [Related]
23. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
[TBL] [Abstract][Full Text] [Related]
24. Suitability of Yin Yang 1 transcript and protein levels for biomarker studies in B cell non-Hodgkin lymphoma.
Arribas Arranz J; Winter DN; Drexler HG; Eberth S
Biomark Res; 2018; 6():11. PubMed ID: 29564133
[TBL] [Abstract][Full Text] [Related]
25. DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression.
Xie VK; Li Z; Yan Y; Jia Z; Zuo X; Ju Z; Wang J; Du J; Xie D; Xie K; Wei D
Clin Cancer Res; 2017 Sep; 23(18):5585-5597. PubMed ID: 28659310
[No Abstract] [Full Text] [Related]
26. Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.
Lin ZS; Chu HC; Yen YC; Lewis BC; Chen YW
PLoS One; 2012; 7(8):e43593. PubMed ID: 22937066
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic effect caspase activation dependent of a genetically engineered fusion protein with a CD154 peptide mimetic (OmpC-CD154
Pantoja-Escobar G; Morales-Martínez M; Vega GG; Castro-Escarpulli G; Vega MI
Leuk Lymphoma; 2019 Apr; 60(4):1062-1070. PubMed ID: 30277117
[TBL] [Abstract][Full Text] [Related]
28. Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions.
Vega MI; Huerta-Yepez S; Martinez-Paniagua M; Martinez-Miguel B; Hernandez-Pando R; González-Bonilla CR; Chinn P; Hanna N; Hariharan K; Jazirehi AR; Bonavida B
Clin Cancer Res; 2009 Nov; 15(21):6582-94. PubMed ID: 19861448
[TBL] [Abstract][Full Text] [Related]
29. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
[TBL] [Abstract][Full Text] [Related]
30. RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells
Liu S; Xing Y; Lu W; Li S; Tian Z; Xing H; Tang K; Xu Y; Rao Q; Wang M; Wang J
Haematologica; 2019 Aug; 104(8):1597-1607. PubMed ID: 30792202
[TBL] [Abstract][Full Text] [Related]
31. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
32. Kruppel-like factor 4 is a novel mediator of selenium in growth inhibition.
Liu S; Zhang H; Zhu L; Zhao L; Dong Y
Mol Cancer Res; 2008 Feb; 6(2):306-13. PubMed ID: 18314491
[TBL] [Abstract][Full Text] [Related]
33. Krüppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 Expression.
He H; Li S; Hong Y; Zou H; Chen H; Ding F; Wan Y; Liu Z
J Biol Chem; 2015 May; 290(21):13567-77. PubMed ID: 25851906
[TBL] [Abstract][Full Text] [Related]
34. Krüppel-Like Factor 4 and Its Activator APTO-253 Induce NOXA-Mediated, p53-Independent Apoptosis in Triple-Negative Breast Cancer Cells.
Nakajima W; Miyazaki K; Asano Y; Kubota S; Tanaka N
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918002
[TBL] [Abstract][Full Text] [Related]
35. Krüppel-like factor 4 regulates B cell number and activation-induced B cell proliferation.
Klaewsongkram J; Yang Y; Golech S; Katz J; Kaestner KH; Weng NP
J Immunol; 2007 Oct; 179(7):4679-84. PubMed ID: 17878366
[TBL] [Abstract][Full Text] [Related]
36. Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis.
Martínez-Paniagua MA; Baritaki S; Huerta-Yepez S; Ortiz-Navarrete VF; González-Bonilla C; Bonavida B; Vega MI
Cell Cycle; 2011 Aug; 10(16):2792-805. PubMed ID: 21822052
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis.
Jazirehi AR; Bonavida B
Mol Cancer Ther; 2004 Jan; 3(1):71-84. PubMed ID: 14749477
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of miR-34a ameliorates inflammatory response and apoptosis induced by renal ischemia-reperfusion by promoting Kruppel-like factor 4 expression.
Shi YY; Ma YH; Zhang R; Li RS
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11683-11689. PubMed ID: 33275236
[TBL] [Abstract][Full Text] [Related]
40. Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression.
Castellano G; Torrisi E; Ligresti G; Nicoletti F; Malaponte G; Traval S; McCubrey JA; Canevari S; Libra M
Cell Cycle; 2010 Feb; 9(3):557-63. PubMed ID: 20081364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]